{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:42Z","timestamp":1784408862535,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,26]]},"DOI":"10.7759\/cureus.84854","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:38:31Z","timestamp":1748299111000},"source":"Crossref","is-referenced-by-count":1,"title":["Dermatomyositis, Rhabdomyolysis, and Statin-Induced Myopathy: A Case Report Illustrating the Spectrum of Myopathy"],"prefix":"10.7759","author":[{"given":"Htet Zaw","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Laung","family":"Khay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmar","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vui  H","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000015","article-title":"The spectrum of renal involvement in patients with inflammatory myopathies","volume":"93","author":"Couvrat-Desvergnes G","year":"2014","unstructured":"Couvrat-Desvergnes G, Masseau A, Benveniste O, et al.. The spectrum of renal involvement in patients with inflammatory myopathies. Medicine (Baltimore). 2014, 93:33-41. 10.1097\/MD.0000000000000015","journal-title":"Medicine (Baltimore)"},{"key":"ref3","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8524-5","article-title":"Renal involvement in idiopathic inflammatory myopathies","volume":"52","author":"Cucchiari D","year":"2017","unstructured":"Cucchiari D, Angelini C. Renal involvement in idiopathic inflammatory myopathies. Clin Rev Allergy Immunol. 2017, 52:99-107. 10.1007\/s12016-015-8524-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients","volume":"84","author":"Melli G","year":"2005","unstructured":"Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005, 84:377-85.","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2014.05.005","article-title":"Rhabdomyolysis: review of the literature","volume":"24","author":"Zutt R","year":"2014","unstructured":"Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014, 24:651-9. 10.1016\/j.nmd.2014.05.005","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15757","article-title":"Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins","volume":"89","author":"Montastruc JL","year":"2023","unstructured":"Montastruc JL. Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins. Br J Clin Pharmacol. 2023, 89:2636-8. 10.1111\/bcp.15757","journal-title":"Br J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8125","article-title":"Polymyositis presenting as rhabdomyolysis after the initiation of omeprazole","volume":"12","author":"Jakubowski JK","year":"2020","unstructured":"Jakubowski JK, Patel R, Buddharaju V. Polymyositis presenting as rhabdomyolysis after the initiation of omeprazole. Cureus. 2020, 12:10.7759\/cureus.8125","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.5418","article-title":"Causes and clinical presentation of drug-induced dermatomyositis: a systematic review","volume":"160","author":"Caravan S","year":"2024","unstructured":"Caravan S, Lopez CM, Yeh JE. Causes and clinical presentation of drug-induced dermatomyositis: a systematic review. JAMA Dermatol. 2024, 160:210-7. 10.1001\/jamadermatol.2023.5418","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24778","article-title":"Refractory statin-induced immune-mediated necrotizing myositis: challenges and perils in its management","volume":"14","author":"Yeo CH","year":"2022","unstructured":"Yeo CH, Yaakub A, Wang MC, et al.. Refractory statin-induced immune-mediated necrotizing myositis: challenges and perils in its management. Cureus. 2022, 14:10.7759\/cureus.24778","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis\u2009-\u2009(first of two parts)","volume":"292","author":"Bohan A","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis\u2009-\u2009(first of two parts). N Engl J Med. 1975, 292:344-7. 10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S197941","article-title":"Statin-associated autoimmune myopathy: current perspectives","volume":"16","author":"Tiniakou E","year":"2020","unstructured":"Tiniakou E. Statin-associated autoimmune myopathy: current perspectives. Ther Clin Risk Manag. 2020, 16:483-92. 10.2147\/TCRM.S197941","journal-title":"Ther Clin Risk Manag"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3138\/ptc.2012-65","article-title":"Statin-induced rhabdomyolysis: a comprehensive review of case reports","volume":"66","author":"Mendes P","year":"2014","unstructured":"Mendes P, Robles PG, Mathur S. Statin-induced rhabdomyolysis: a comprehensive review of case reports. Physiother Can. 2014, 66:124-32. 10.3138\/ptc.2012-65","journal-title":"Physiother Can"},{"key":"ref14","article-title":"Dermatomyositis","author":"Qudsiya Z","year":"2025","unstructured":"Qudsiya Z, Waseem M. Dermatomyositis. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref15","article-title":"HMG-CoA reductase inhibitors","author":"Bansal AB","year":"2025","unstructured":"Bansal AB, Cassagnol M. HMG-CoA reductase inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac100","article-title":"Genetic analysis for type 1 diabetes genes in juvenile dermatomyositis unveils genetic disease overlap","volume":"61","author":"Qu HQ","year":"2022","unstructured":"Qu HQ, Qu J, Vaccaro C, et al.. Genetic analysis for type 1 diabetes genes in juvenile dermatomyositis unveils genetic disease overlap. Rheumatology (Oxford). 2022, 61:3497-3501. 10.1093\/rheumatology\/keac100","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","article-title":"Dermatomyositis following rhabdomyolysis","volume":"3","author":"Marks SH","year":"1976","unstructured":"Marks SH, McShane DJ, Mitchell DM. Dermatomyositis following rhabdomyolysis. J Rheumatol. 1976, 3:224-6.","journal-title":"J Rheumatol"},{"key":"ref18","article-title":"Dermatomyositis presenting with rhabdomyolysis and acute renal failure; an uncommon manifestation","volume":"12","author":"Joshi D","year":"2009","unstructured":"Joshi D, Kumar N, Rai A. Dermatomyositis presenting with rhabdomyolysis and acute renal failure; an uncommon manifestation. Ann Indian Acad Neurol. 2009, 12:45-7.","journal-title":"Ann Indian Acad Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.843753","article-title":"A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin","volume":"25","author":"Mizoguchi F","year":"2015","unstructured":"Mizoguchi F, Takada K, Ishikawa K, Mizusawa H, Kohsaka H, Miyasaka N. A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin. Mod Rheumatol. 2015, 25:646-8. 10.3109\/14397595.2013.843753","journal-title":"Mod Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12077","article-title":"ermatomyositis-induced rhabdomyolysis with features of necrotizing myopathy and acute inflammatory demyelinating polyneuropathy in an Epstein-Barr virus infected patient","volume":"12","author":"Haikal A","year":"2020","unstructured":"Haikal A, Govil S, Anis A, Guma J. ermatomyositis-induced rhabdomyolysis with features of necrotizing myopathy and acute inflammatory demyelinating polyneuropathy in an Epstein-Barr virus infected patient. Cureus. 2020, 12:10.7759\/cureus.12077","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.33552\/ARAR.2020.01.000512","article-title":"A case of dermatomyositis presenting with fulminant rhabdomyolysis without myoglobinuric acute kidney injury - a rare clinical manifestation","volume":"1","author":"Gomes RR","year":"2020","unstructured":"Gomes RR, Khan SB. A case of dermatomyositis presenting with fulminant rhabdomyolysis without myoglobinuric acute kidney injury - a rare clinical manifestation. Arch Rheumatol Arthritis Res. 2020, 1:1-5.","journal-title":"Arch Rheumatol Arthritis Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-023-00507-y","article-title":"An undifferentiated cause of rhabdomyolysis: a case report","volume":"16","author":"Patil P","year":"2023","unstructured":"Patil P, Davidson J, Patel S. An undifferentiated cause of rhabdomyolysis: a case report. Int J Emerg Med. 2023, 16:10.1186\/s12245-023-00507-y","journal-title":"Int J Emerg Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.10.020","article-title":"Anti-NXP2 positive dermatomyositis causing rhabdomyolysis: an atypical presentation","volume":"363","author":"Shah V","year":"2022","unstructured":"Shah V, Yaffe B, Gutman D. Anti-NXP2 positive dermatomyositis causing rhabdomyolysis: an atypical presentation. Am J Med Sci. 2022, 363:49-50. 10.1016\/j.amjms.2021.10.020","journal-title":"Am J Med Sci"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1097\/01720610-201208000-00006","article-title":"Statin-induced rhabdomyolysis and dermatomyositis: a rare combination","volume":"25","author":"Cannon CS","year":"2012","unstructured":"Cannon CS. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination. JAAPA. 2012, 25:30-2.","journal-title":"JAAPA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00447_10.x","article-title":"Severe dermatomyositis with rhabdomyolysis and paralytic ileus: a case successfully treated with plasmapheresis and intravenous immunoglobulin","volume":"9","author":"Fukunaga E","year":"2002","unstructured":"Fukunaga E, Kunishige M, Mitsui T, et al.. Severe dermatomyositis with rhabdomyolysis and paralytic ileus: a case successfully treated with plasmapheresis and intravenous immunoglobulin. Eur J Neurol. 2002, 9:697-8. 10.1046\/j.1468-1331.2002.00447_10.x","journal-title":"Eur J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/03009749950154301","article-title":"Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss","volume":"28","author":"Kofteridis DP","year":"1999","unstructured":"Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK, Vamvakas LN, Emmanouel DS. Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss. Scand J Rheumatol. 1999, 28:192-4. 10.1080\/03009749950154301","journal-title":"Scand J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2022.2070974","article-title":"Severe rhabdomyolysis due to idiopathic inflammatory myopathies, a wary manifestation of a heterogenous pathology","volume":"78","author":"Schepens N","year":"2023","unstructured":"Schepens N, Herroelen PH, Decavele AS, Vanacker A. Severe rhabdomyolysis due to idiopathic inflammatory myopathies, a wary manifestation of a heterogenous pathology. Acta Clin Belg. 2023, 78:160-4. 10.1080\/17843286.2022.2070974","journal-title":"Acta Clin Belg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.7.723","article-title":"Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis","volume":"60","author":"Marie I","year":"2001","unstructured":"Marie I, Levesque H, Cailleux N, Courtois H, Gu\u00e9don C. Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis. Ann Rheum Dis. 2001, 60:723-4. 10.1136\/ard.60.7.723","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(98)70191-6","article-title":"Adult-onset dermatomyositis with severe gastrointestinal manifestations: case report and review of the literature","volume":"123","author":"Eshraghi N","year":"1998","unstructured":"Eshraghi N, Farahmand M, Maerz LL, et al.. Adult-onset dermatomyositis with severe gastrointestinal manifestations: case report and review of the literature. Surgery. 1998, 123:356-8. 10.1016\/S0039-6060(98)70191-6","journal-title":"Surgery"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omx063","article-title":"Aggressive and fatal statin-induced dermatomyositis: a case report","volume":"2017","author":"Chemello RM","year":"2017","unstructured":"Chemello RM, Benvegn\u00fa AM, Dallazem LN, Chemello D. Aggressive and fatal statin-induced dermatomyositis: a case report. Oxf Med Case Rep. 2017, 2017:10.1093\/omcr\/omx063","journal-title":"Oxf Med Case Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7387","article-title":"Weak knees: a case of atorvastatin-induced dermatomyositis","volume":"12","author":"Gutierrez E","year":"2020","unstructured":"Gutierrez E, Faraji M, Pacheco L. Weak knees: a case of atorvastatin-induced dermatomyositis. Cureus. 2020, 12:10.7759\/cureus.7387","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20127","article-title":"Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake","volume":"30","author":"Vasconcelos OM","year":"2004","unstructured":"Vasconcelos OM, Campbell WW. Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake. Muscle Nerve. 2004, 30:803-7. 10.1002\/mus.20127","journal-title":"Muscle Nerve"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/genes16030248","article-title":"The association between statin drugs and rhabdomyolysis: an analysis of FDA Adverse Event Reporting System (FAERS) data and transcriptomic profiles","volume":"16","author":"Morris R","year":"2025","unstructured":"Morris R, Bu K, Han W, et al.. The association between statin drugs and rhabdomyolysis: an analysis of FDA Adverse Event Reporting System (FAERS) data and transcriptomic profiles. Genes (Basel). 2025, 16:10.3390\/genes16030248","journal-title":"Genes (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin toxicity: mechanistic insights and clinical implications","volume":"124","author":"Ward NC","year":"2019","unstructured":"Ward NC, Watts GF, Eckel RH. Statin toxicity: mechanistic insights and clinical implications. Circ Res. 2019, 124:328-50. 10.1161\/CIRCRESAHA.118.312782","journal-title":"Circ Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.051722","article-title":"Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions","volume":"41","author":"Shirasaka Y","year":"2013","unstructured":"Shirasaka Y, Sager JE, Lutz JD, Davis C, Isoherranen N. Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions. Drug Metab Dispos. 2013, 41:1414-24. 10.1124\/dmd.113.051722","journal-title":"Drug Metab Dispos"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231156270","article-title":"Proton pump inhibitors and rhabdomyolysis: analysis of two different cross-sectional databases","volume":"57","author":"Mitsuboshi S","year":"2023","unstructured":"Mitsuboshi S, Hamano H, Kuniki Y, et al.. Proton pump inhibitors and rhabdomyolysis: analysis of two different cross-sectional databases. Ann Pharmacother. 2023, 57:1255-63. 10.1177\/10600280231156270","journal-title":"Ann Pharmacother"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0473-2","article-title":"Proton pump inhibitors and risk of rhabdomyolysis","volume":"40","author":"Duncan SJ","year":"2017","unstructured":"Duncan SJ, Howden CW.  Proton pump inhibitors and risk of rhabdomyolysis. Drug Saf. 2017, 40:61-4. 10.1007\/s40264-016-0473-2","journal-title":"Drug Saf"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)92008-7","article-title":"Autoimmune syndrome induced by omeprazole","volume":"344","author":"Sivakumar K","year":"1994","unstructured":"Sivakumar K, Dalakas M. Autoimmune syndrome induced by omeprazole. Lancet. 1994, 344:619-20. 10.1016\/s0140-6736(94)92008-7","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas MC","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al.. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993, 329:1993-2000. 10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370450-dermatomyositis-rhabdomyolysis-and-statin-induced-myopathy-a-case-report-illustrating-the-spectrum-of-myopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:38:33Z","timestamp":1748299113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370450-dermatomyositis-rhabdomyolysis-and-statin-induced-myopathy-a-case-report-illustrating-the-spectrum-of-myopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.84854","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}